Personalized Treatment for Patients With Lung Cancer

Personalized Treatment for Patients With Lung Cancer - PMC

Personalized first-line treatment of non-small-cell lung cancer. The most important biomarker to guide treatment of patients with squamous cell carcinoma of the ...

Personalized Treatment for Patients With Lung Cancer - PubMed

In addition to the implementation of lung cancer screening in high-risk populations, the further development and consistent implementation ...

Personalised Medicine at a Glance: Lung Cancer

Even in the absence of identified molecular abnormalities that lead to specific drug treatments, care of lung cancer patients can be personalised in many ...

Personalised medicine for nonsmall cell lung cancer

Gefitinib, erlotinib and afatinib have been approved and are recommended in first-line therapy in advanced NSCLC with activating mutations in the tyrosine ...

Toward personalized treatment approaches for non-small-cell lung ...

Molecular targeted therapies and immunotherapies for non-small-cell lung cancer (NSCLC) have improved outcomes markedly over the past two ...

Personalized, genotype-directed therapy for advanced non-small ...

Treatment for patients with metastatic non-small cell lung cancer (NSCLC) has historically consisted of systemic cytotoxic chemotherapy.

Are We Ready for Personalized Treatment in Small Cell Lung Cancer?

Recent incorporation of immunotherapy in addition to platinum-based chemotherapy has brought moderate benefit to patients with SCLC.

Personalized Treatment for Patients With Lung Cancer (28.04.2023)

This review of the diagnosis and treatment of lung cancer is based on current national and international guidelines, and on prospective trials.

predicting personalized immunotherapy outcomes in lung cancer

Personalized medicine has revolutionized approaches to treatment in the field of lung cancer by enabling therapies to be specific to each ...

Personalized therapy for lung cancer: striking a moving target

Molecular targeted therapy heralded a new era for the treatment of patients with oncogene-driven advanced-stage non–small-cell lung cancer ...

Personalized medicine for lung cancer gets closer look

Abhinav Jha's latest NIH grant another step toward early prediction of therapy response in patients with lung cancer.

Personalized medicine of non-gene-specific chemotherapies for non ...

Non-small cell lung cancer (NSCLC), because of its unrivaled prevalence and lethality, is by many measures the most urgent cancer-related challenge facing ...

Personalized Treatment in Non-Small Cell Lung Cancer

Personalized treatment means aligning cancer care to the individual characteristics of a patient's tumor, often identified through biomarker testing. In NSCLC, ...

Precision or Personalized Medicine - American Cancer Society

Precision medicine is a way health care providers can offer and plan specific care for their patients, based on the particular genes, proteins, and other ...

Impact of Clinical Practice Gaps on the Implementation of ...

Personalized medicine presents new opportunities for patients with cancer. However, many patients do not receive the most effective ...

Personalized Medicine for Lung Cancer - Taylor & Francis Online

A vanguard model for successful personalized therapy for lung cancer targets activating mutations in EGFR with EGFR tyrosine kinase inhibitors (e.g., first- ...

Lung Cancer and Personalized Medicine: Novel Therapies and ...

Provides a better understanding of lung cancer, the factors that make it lethal, and current research focused on developing personalized treatment plans ...

Challenges in Implementing Personalized Medicine for Lung ... - MDPI

The traditional approach to the treatment of advanced non-small cell lung cancer (NSCLC) relied on the uniform use of cytotoxic chemotherapy.

Personalized Treatments Advance Survival Outcomes for Patients ...

The pathology of lung cancer will guide treatment decisions. Lung cancers can be classified into 2 major groups: non–small cell lung cancer ( ...

Personalized Diagnostic Workflows: The Next Wave of Precision ...

∙ Aisner, D.L. ... Updated molecular testing guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors ...